The global recombinant peptide market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Peptides are extremely active and highly specific drug substances. They are used in an extensive range of therapeutic areas on account of the diversity of their biological functions. Peptides are gradually entering drug development pathways as potential active pharmaceutical ingredients (API) on the back of their hefty chemical space, high biological activity, high specificity, relative ease of synthesis, ready availability, and low toxicity. The market growth is expected to be driven by the surging use of peptides in pharmaceutical drugs, growth in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers across the globe.
Get Free Sample link @ https://www.omrglobal.com/request-sample/recombinant-peptide-market
Peptides are extensively used in three prominent therapeutics areas namely oncology, diabetes, and obesity. Moreover, the demand for peptides is soaring for the treatment of cardiovascular and neurodegenerative diseases, renal failure, and rare diseases. Further, the development of personalized medicines globally is expected to create ample opportunities for market growth in the near future. Interest in personalized treatment has been driven by the concept of tailored therapy with the best response and highest safety margin to ensure better patient care. Some key players operating in the market include Amgen Inc., Novartis International AG, and Biocon Ltd., among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
Full report of Recombinant Peptide Market available @ https://www.omrglobal.com/industry-reports/recombinant-peptide-market
Market Coverage
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Amgen Inc., Novartis International AG, and Biocon Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Recombinant Peptide Market Report by Segment
By Type
- Glucagon
- Calcitonin
- Others
By Application
- Oncology
- Blood Disorders
- Infectious Diseases
- Autoimmune Diseases
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/recombinant-peptide-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
